Process for preparing distamycin derivatives
AssigneePharmacia Italia S.p.A.
InventorsItalo Beria, Paolo Cozzi, Nicola Mongelli, Fabrizio Orzi
Life of this patent
Estimating the term…
Abstract
Compounds which are α-halogenoacryloyl distamycin derivatives of formula (I) wherein R1 is a bromine or chlorine atom; R2 is a distamycin or distamycin-like framework as set forth in the specification; or a pharmaceutically acceptable salt thereof; are cytotoxic agents particularly effective in the treatment of tumors over expressing GSH/GSTs system and which are poorly responsive or even resistant to conventional antitumor therapies.
Claims12
A process for preparing a poly-pyrroleamido derivative of formula
- 16
- wherein P is a hydrogen atom or a suitable amino protecting group, which process comprises:
- a) hydrolysing distamycin A under basic conditions and properly protecting the resulting amino group so as to obtain a compound of formula
- 17
- wherein P is a suitable amino protecting group;
- b) reacting the compound of formula (II) with diphenylphosphorylazide (DPPA), so as to obtain a compound of formula
- 18
- c) hydrolysing under basic conditions the compound of formula (III) so as to obtain the derivative of formula
- 19
- d) reacting the compound of formula (IV) with a suitable guanylating agent so as to obtain the derivative of formula
- 20
- wherein P1 and P2, the same, are hydrogen atoms or amino protecting groups equal or different to P and, when P1 and P2 are other than hydrogen atoms,
- e) deprotecting the guanidino and the amino group so as to obtain the derivative of formula (I).
A compound of formula
- 22
- wherein P is hydrogen or a suitable amino protecting group.
A process for preparing distamycin-guanidines of formula
- 23
- wherein
- R is selected from the group consisting of:
- 24
- wherein
- R1 and R2 are chlorine or bromine atoms;
- R3 is hydrogen, chlorine or bromine;
- X and Y, the same or different, are selected from nitrogen or CH groups;
- W is phenylene or a benzocondensed 5 or 6 membered heterocycle with 1 or 2 heteroatoms selected among N, O or S, both of which being optionally further substituted by lower alkyl groups;
- or pharmaceutically acceptable salts thereof;
- which process comprises:
- a) hydrolysing distamycin A under basic conditions and properly protecting the resulting amino group so as to obtain a compound of formula
- 25
- wherein P is a suitable amino protecting group;
- b) reacting the compound of formula (II) with diphenylphosphorylazide (DPPA), so as to obtain a compound of formula
- 26
- c) hydrolysing under basic conditions the compound of formula (III) so as to obtain the derivative of formula
- 27
- d) reacting the compound of formula (IV) with a suitable guanylating agent so as to obtain the derivative of formula
- 28
- wherein P1 and P2, the same, are hydrogen atoms or amino protecting groups equal or different to P and, when P1 and P2 are other than hydrogen atoms,
- e) deprotecting the guanidino and the amino group so as to obtain the derivative of formula
- 29
- wherein P is hydrogen;
- f) acylating the compound of formula (I) with a carboxylic derivative of formula
- R—COZ (VIII)
- wherein R has the above reported meanings and Z is hydroxy or a suitable leaving group, so as to obtain the compounds of formula (VII) and, whenever desired, converting them into pharmaceutically acceptable salts.
Dependencies are inferred from the claim text.